Axis Bank's Strategic Infusion: Rs 1,500 Crore Fuel for Axis Finance's Growth

Axis Bank has approved a Rs 1,500 crore infusion into its subsidiary, Axis Finance Ltd, via a rights issue. This strategic move is aimed at fostering business growth, utilizing a phased investment approach by March 31, 2027. The Reserve Bank of India has given the necessary approvals.

Axis Bank has announced a substantial Rs 1,500 crore capital infusion into its non-banking financial subsidiary, Axis Finance Ltd (AFL), to support business expansion efforts. The decision was made during a board meeting on March 18, 2026, according to an official regulatory filing by the bank.

The infusion will be carried out through a rights issue and is expected to be completed in multiple tranches by the end of March 2027. This move aligns with the bank's strategic objectives to bolster the financial strength and growth prospects of AFL, which operates as a fully-owned subsidiary.

Approval from the Reserve Bank of India, granted in March 2026, paves the way for this significant financial maneuver, signaling confidence in AFL's performance trajectory following a Rs 2,504 crore turnover for the half-year ended FY26.

(With inputs from agencies.)